These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 19757302)
1. T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy-cell leukemia correlates with interferon-gamma production. Jöhrens K; Moos V; Schneider T; Anagnostopoulos I Leuk Lymphoma; 2009 Oct; 50(10):1687-92. PubMed ID: 19757302 [TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. Bürgler S; Gimeno A; Parente-Ribes A; Wang D; Os A; Devereux S; Jebsen P; Bogen B; Tjønnfjord GE; Munthe LA J Immunol; 2015 Jan; 194(2):827-35. PubMed ID: 25505279 [TBL] [Abstract][Full Text] [Related]
3. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia. Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083 [TBL] [Abstract][Full Text] [Related]
4. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients. Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440 [TBL] [Abstract][Full Text] [Related]
5. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway. Yokosawa M; Kondo Y; Tahara M; Iizuka-Koga M; Segawa S; Kaneko S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T Clin Exp Immunol; 2017 Apr; 188(1):22-35. PubMed ID: 27936495 [TBL] [Abstract][Full Text] [Related]
6. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Gao M; Jin W; Qian Y; Ji L; Feng G; Sun J Cytokine; 2011 Nov; 56(2):458-65. PubMed ID: 21795061 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Babuŝíková O; Tomová A; Kusenda J; Gyárfás J Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978 [TBL] [Abstract][Full Text] [Related]
8. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia. Kluin-Nelemans JC; Kester MG; Oving I; Cluitmans FH; Willemze R; Falkenburg JH Leukemia; 1994 Dec; 8(12):2095-101. PubMed ID: 7807997 [TBL] [Abstract][Full Text] [Related]
9. IL-4 gene transcription in human T cells is suppressed by T-bet. Kitamura N; Kitamura F; Kaminuma O; Miyatake S; Tatsumi H; Nemoto S; Mori A Int Arch Allergy Immunol; 2007; 143 Suppl 1():68-70. PubMed ID: 17541280 [TBL] [Abstract][Full Text] [Related]
10. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines. Jöhrens K; Stein H; Anagnostopoulos I Am J Surg Pathol; 2007 Aug; 31(8):1181-5. PubMed ID: 17667540 [TBL] [Abstract][Full Text] [Related]
11. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function. Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360 [TBL] [Abstract][Full Text] [Related]
12. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X; Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538 [TBL] [Abstract][Full Text] [Related]
13. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590 [TBL] [Abstract][Full Text] [Related]
14. IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+ T cells. Ylikoski E; Lund R; Kyläniemi M; Filén S; Kilpeläinen M; Savolainen J; Lahesmaa R Eur J Immunol; 2005 Nov; 35(11):3297-306. PubMed ID: 16220539 [TBL] [Abstract][Full Text] [Related]
15. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation. Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754 [TBL] [Abstract][Full Text] [Related]
17. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Zhu K; Ye J; Wu M; Cheng H Arch Dermatol Res; 2010 Sep; 302(7):517-23. PubMed ID: 20333526 [TBL] [Abstract][Full Text] [Related]
18. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857 [TBL] [Abstract][Full Text] [Related]
19. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity. Kawashima M; Miossec P Ann Rheum Dis; 2005 Mar; 64(3):415-8. PubMed ID: 15286007 [TBL] [Abstract][Full Text] [Related]
20. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]